亞洲果業(00073.HK)擬按"2供1"進行供股 淨籌4240萬港元
格隆匯9月11日丨亞洲果業(00073.HK)公吿,公司建議按於記錄日期每持有兩(2)股現有股份獲發一(1)股供股股份的基準,以認購價每股供股股份0.035港元進行供股,透過向合資格股東發行最多1,249,818,942股供股股份籌集最多約4370萬港元(未扣除開支)。合資格股東有權申請認購超出彼等各自於供股項下配額的供股股份。
假設供股所得款項淨額將約為4240萬港元,公司有意動用該等所得款項淨額如下:當中約(i)70%所得款項淨額用作開拓及發展空調分銷及安裝業務的營運資金;(ii)20%所得款項淨額用作撥付不時認定的任何投資機遇;及(iii)餘下10%所得款項淨額用作集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.